脳科学辞典

ストローマ細胞由来因子-1

2025年8月15日 (金) 21:55時点におけるWikiSysop (トーク | 投稿記録)による版 (ページの作成:「<ref name=Nagasawa1994><pubmed>8757135</pubmed></ref> <ref name=Murphy2007><pubmed>17264079</pubmed></ref> <ref name=Yu2006>NoID</ref> <ref name=DeLaLuzSierra2004><pubmed>14525775</pubmed></ref> <ref name=Liu2024><pubmed>39093700</pubmed></ref> <ref name=Zou1998><pubmed>9634238</pubmed></ref> <ref name=McGrath1999><pubmed>10479460</pubmed></ref> <ref name=Luker2006>NoID</ref> <ref name=Li2008>NoID</ref> <ref name=Petit2002><pubmed>12068293</pubmed></ref> <ref name=M…」)

(差分) ← 古い版 | 承認済み版 (差分) | 最新版 (差分) | 新しい版 → (差分)

[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18]

  1. ↑ Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., ..., & Kishimoto, T. (1996).
    Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382(6592), 635-8. [PubMed:8757135] [WorldCat] [DOI]
  2. ↑ Murphy, J.W., Cho, Y., Sachpatzidis, A., Fan, C., Hodsdon, M.E., & Lolis, E. (2007).
    Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. The Journal of biological chemistry, 282(13), 10018-10027. [PubMed:17264079] [PMC] [WorldCat] [DOI]
  3. ↑ NoID
  4. ↑ De La Luz Sierra, M., Yang, F., Narazaki, M., Salvucci, O., Davis, D., Yarchoan, R., ..., & Tosato, G. (2004).
    Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood, 103(7), 2452-9. [PubMed:14525775] [WorldCat] [DOI]
  5. ↑ Liu, Y., Liu, A., Li, X., Liao, Q., Zhang, W., Zhu, L., & Ye, R.D. (2024).
    Cryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state. Cell reports, 43(8), 114578. [PubMed:39093700] [WorldCat] [DOI]
  6. ↑ Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., & Littman, D.R. (1998).
    Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393(6685), 595-9. [PubMed:9634238] [WorldCat] [DOI]
  7. ↑ McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K., & Palis, J. (1999).
    Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Developmental biology, 213(2), 442-56. [PubMed:10479460] [WorldCat] [DOI]
  8. ↑ NoID
  9. ↑ NoID
  10. ↑ Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., ..., & Lapidot, T. (2002).
    G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nature immunology, 3(7), 687-94. [PubMed:12068293] [WorldCat] [DOI]
  11. ↑ Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., ..., & Springer, T.A. (1998).
    Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9448-53. [PubMed:9689100] [PMC] [WorldCat] [DOI]
  12. ↑ Wu, B., Chien, E.Y., Mol, C.D., Fenalti, G., Liu, W., Katritch, V., ..., & Stevens, R.C. (2010).
    Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (New York, N.Y.), 330(6007), 1066-71. [PubMed:20929726] [PMC] [WorldCat] [DOI]
  13. ↑ NoID
  14. ↑ Robin, A.M., Zhang, Z.G., Wang, L., Zhang, R.L., Katakowski, M., Zhang, L., ..., & Chopp, M. (2006).
    Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 26(1), 125-34. [PubMed:15959456] [WorldCat] [DOI]
  15. ↑ Kanayama, T., Hatakeyama, M., Akiyama, N., Otsu, Y., Onodera, O., Shimohata, T., & Kanazawa, M. (2025).
    Oxygen-glucose-deprived peripheral blood mononuclear cells act on hypoxic lesions after ischemia-reperfusion injury. Experimental neurology, 385, 115121. [PubMed:39710242] [WorldCat] [DOI]
  16. ↑ Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R.M., ..., & Meinl, E. (2006).
    Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain : a journal of neurology, 129(Pt 1), 200-11. [PubMed:16280350] [WorldCat] [DOI]
  17. ↑ Duggan, M.R., Yang, Z., Cui, Y., Dark, H.E., Wen, J., Erus, G., ..., & Walker, K.A. (2024).
    Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20(9), 6486-6505. [PubMed:39129354] [PMC] [WorldCat] [DOI]
  18. ↑ De Clercq, E. (2019).
    Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. Antiviral chemistry & chemotherapy, 27, 2040206619829382. [PubMed:30776910] [PMC] [WorldCat] [DOI]
「https://bsd.neuroinf.jp/w/index.php?title=ストローマ細胞由来因子-1&oldid=51384」から取得